Skip to content
MatchScript
Menu

Evidence review

Compounded vs Brand-Name GLP-1: Which Fits Your Situation

Compounded and brand-name GLP-1s differ on price, evidence, and oversight. A measured guide to which fits your budget, goals, and comfort level.

By The MatchScript Team, Matching & Recommendations Desk

If you've priced GLP-1 medications, you've seen the gap: brand-name Wegovy or Zepbound can run many hundreds of dollars a month, while compounded semaglutide and tirzepatide often start well under $200. That gap is real and it's confusing, so let's walk through what actually separates the two — and which one fits your situation. Pricing figures throughout reflect each provider's published pricing (last reviewed 2026).

What "brand-name" means Brand-name GLP-1s are FDA-approved finished products. Wegovy (semaglutide) is approved for chronic weight management[[cite:1]], and Zepbound (tirzepatide) is approved for the same use[[cite:2]]. "FDA-approved" means the specific product — the exact molecule, dose, and manufacturing — was reviewed for safety, efficacy, and quality, and it's the version studied in the large trials people cite: about 15% average weight loss for semaglutide in STEP-1[[cite:3]] and the low-to-mid 20% range for tirzepatide in SURMOUNT-1[[cite:4]].

What "compounded" means Compounded GLP-1s are prepared by licensed compounding pharmacies rather than sold as approved finished products. Compounding is a legitimate, long-standing part of pharmacy, but compounded drugs are not FDA-approved and are not reviewed the same way brand products are[[cite:5]]. That's the core trade-off: you typically pay much less, but you're relying on the pharmacy's quality and the provider's oversight rather than an FDA approval of that exact product. Our [is compounded GLP-1 legit and safe](/is-compounded-glp1-legit-and-safe) guide covers the 503A/503B distinction and how to vet a pharmacy.

Where compounded fits Compounded makes sense if price is the deciding factor, if brand medication is out of reach without insurance, or if you want a format brand doesn't offer — such as an oral or sublingual route (see [injections vs oral](/injections-vs-oral-glp1)). Many well-run telehealth providers pair compounded medication with real clinician oversight, dose titration, and support. If you go this route, the provider's transparency and pharmacy sourcing matter more than the sticker price alone.

Where brand-name fits Brand-name fits if you want the exact product studied in the trials, if you value the FDA-approval assurance, or if insurance brings the cost within reach. It's also the more predictable path if you have a complex medical history and want the most standardized product. Some providers on our list offer brand access alongside compounded options — you can filter for that in the [comparison hub](/compare).

How to decide Start with two questions: what's my monthly budget, and how much does the FDA-approval assurance matter to me? If budget is tight and you're comfortable with a vetted compounding provider, compounded is a reasonable fit. If assurance and the exact studied product matter most — and cost allows — brand-name is the cleaner choice. Either way, match the molecule to your goal first ([semaglutide vs tirzepatide](/semaglutide-vs-tirzepatide)), then pick the provider.

Let the quiz weigh it for you Not sure which side you land on? The [2-minute quiz](/quiz) asks about budget, medication, and how much the approval assurance matters, then reweights our honest [Match Score](/methodology) to surface providers that fit. You can also compare a value-focused pick like [Found](/reviews/found) against a broader, brand-capable platform in the [alternatives to Ro](/compare/alternatives/ro) view.

Frequently asked questions

Is compounded semaglutide the same as Wegovy?

It's the same molecule, but not the same product. Wegovy is the FDA-approved finished product studied in the STEP trials; compounded semaglutide is prepared by a pharmacy and is not FDA-approved, so it isn't reviewed the same way.

Why is compounded so much cheaper?

Compounded medication isn't a branded, FDA-approved product with the same manufacturing and marketing costs, which is a large part of the price difference. The trade-off is you rely on the pharmacy's quality and the provider's oversight rather than an FDA approval of that exact product.

Which should I choose?

If budget is the deciding factor and you're comfortable with a vetted compounding provider, compounded can fit. If the FDA-approval assurance matters most and cost allows, brand-name is the cleaner choice. The quiz can weigh this for you.

References

  1. U.S. Food and Drug Administration (2021). FDA Approves New Drug Treatment for Chronic Weight Management (Wegovy). FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014
  2. U.S. Food and Drug Administration (2023). FDA Approves New Medication for Chronic Weight Management (Zepbound). FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management
  3. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
  4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
  5. U.S. Food and Drug Administration (2024). Compounding and the FDA: Questions and Answers. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Continue reading